AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives
Stay Up to Date
Sign up now to receive updates through our newsletter regarding new research and more.
